Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 4
1946 21
1947 23
1948 27
1949 29
1950 36
1951 47
1952 37
1953 27
1954 28
1955 23
1956 42
1957 31
1958 36
1959 31
1960 40
1961 39
1962 40
1963 78
1964 119
1965 154
1966 310
1967 377
1968 397
1969 354
1970 422
1971 353
1972 399
1973 493
1974 602
1975 674
1976 709
1977 882
1978 1687
1979 1947
1980 16814
1981 35161
1982 36320
1983 36927
1984 38478
1985 39390
1986 40506
1987 41908
1988 43269
1989 44984
1990 47309
1991 49091
1992 49604
1993 50155
1994 51631
1995 52369
1996 52665
1997 53233
1998 54740
1999 56019
2000 58272
2001 59762
2002 62925
2003 67545
2004 75239
2005 82161
2006 91229
2007 97847
2008 108154
2009 114461
2010 124010
2011 133564
2012 138592
2013 144129
2014 146199
2015 147344
2016 141918
2017 136481
2018 138802
2019 139399
2020 152162
2021 158779
2022 143717
2023 138386
2024 51103
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

3,427,248 results

Results by year

Filters applied: . Clear all
Page 1
Defining the risk of SARS-CoV-2 variants on immune protection.
DeGrace MM, Ghedin E, Frieman MB, Krammer F, Grifoni A, Alisoltani A, Alter G, Amara RR, Baric RS, Barouch DH, Bloom JD, Bloyet LM, Bonenfant G, Boon ACM, Boritz EA, Bratt DL, Bricker TL, Brown L, Buchser WJ, Carreño JM, Cohen-Lavi L, Darling TL, Davis-Gardner ME, Dearlove BL, Di H, Dittmann M, Doria-Rose NA, Douek DC, Drosten C, Edara VV, Ellebedy A, Fabrizio TP, Ferrari G, Fischer WM, Florence WC, Fouchier RAM, Franks J, García-Sastre A, Godzik A, Gonzalez-Reiche AS, Gordon A, Haagmans BL, Halfmann PJ, Ho DD, Holbrook MR, Huang Y, James SL, Jaroszewski L, Jeevan T, Johnson RM, Jones TC, Joshi A, Kawaoka Y, Kercher L, Koopmans MPG, Korber B, Koren E, Koup RA, LeGresley EB, Lemieux JE, Liebeskind MJ, Liu Z, Livingston B, Logue JP, Luo Y, McDermott AB, McElrath MJ, Meliopoulos VA, Menachery VD, Montefiori DC, Mühlemann B, Munster VJ, Munt JE, Nair MS, Netzl A, Niewiadomska AM, O'Dell S, Pekosz A, Perlman S, Pontelli MC, Rockx B, Rolland M, Rothlauf PW, Sacharen S, Scheuermann RH, Schmidt SD, Schotsaert M, Schultz-Cherry S, Seder RA, Sedova M, Sette A, Shabman RS, Shen X, Shi PY, Shukla M, Simon V, Stumpf S, Sullivan NJ, Thackray LB, Theiler J, Thomas PG, Trifkovic S, Türeli S, Turn… See abstract for full author list ➔ DeGrace MM, et al. Nature. 2022 May;605(7911):640-652. doi: 10.1038/s41586-022-04690-5. Epub 2022 Mar 31. Nature. 2022. PMID: 35361968 Free PMC article. Review.
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversit …
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immu …
Will ARPA-H work?
Thorp HH. Thorp HH. Science. 2022 Apr 15;376(6590):223. doi: 10.1126/science.abq4814. Epub 2022 Apr 14. Science. 2022. PMID: 35420930
A new federal agency-approved last month by the United States Congress-is already off to a rocky start. The Advanced Research Projects Agency for Health (ARPA-H), proposed by President Biden in 2021, aims to tackle the most intractable biomedical probl …
A new federal agency-approved last month by the United States Congress-is already off to a rocky start. The Advanced Resear …
Radiation-induced multi-organ injury.
Molinar-Inglis O, DiCarlo AL, Lapinskas PJ, Rios CI, Satyamitra MM, Silverman TA, Winters TA, Cassatt DR. Molinar-Inglis O, et al. Int J Radiat Biol. 2024;100(3):486-504. doi: 10.1080/09553002.2023.2295298. Epub 2024 Jan 2. Int J Radiat Biol. 2024. PMID: 38166195
METHODS: The Radiation and Nuclear Countermeasures Program within the National Institute of Allergy and Infectious Diseases partnered with the Biomedical Advanced Research and Development Authority to convene a virtual two-d …
METHODS: The Radiation and Nuclear Countermeasures Program within the National Institute of Allergy and …
The research agenda of the National Institute of Allergy and Infectious Diseases for antimicrobial resistance.
Peters NK, Dixon DM, Holland SM, Fauci AS. Peters NK, et al. J Infect Dis. 2008 Apr 15;197(8):1087-93. doi: 10.1086/533451. J Infect Dis. 2008. PMID: 18419527 Review.
Antimicrobial resistance is an intrinsic and inevitable aspect of microbial survival that continually challenges human health. Research on antimicrobial resistance is central to the mission of the National Institute of Allergy a …
Antimicrobial resistance is an intrinsic and inevitable aspect of microbial survival that continually challenges human health. …
Overcoming Waning Immunity in Pertussis Vaccines: Workshop of the National Institute of Allergy and Infectious Diseases.
Damron FH, Barbier M, Dubey P, Edwards KM, Gu XX, Klein NP, Lu K, Mills KHG, Pasetti MF, Read RC, Rohani P, Sebo P, Harvill ET. Damron FH, et al. J Immunol. 2020 Aug 15;205(4):877-882. doi: 10.4049/jimmunol.2000676. J Immunol. 2020. PMID: 32769142 Free PMC article. Review.
This is attributed in part to the suboptimal and short-lived immunity elicited by acellular pertussis vaccines and to their inability to prevent nasal colonization and transmission of the etiologic agent Bordetella pertussis In response to this escalating public health con …
This is attributed in part to the suboptimal and short-lived immunity elicited by acellular pertussis vaccines and to their inability to pre …
Update on biphasic anaphylaxis.
Lee S, Sadosty AT, Campbell RL. Lee S, et al. Curr Opin Allergy Clin Immunol. 2016 Aug;16(4):346-51. doi: 10.1097/ACI.0000000000000279. Curr Opin Allergy Clin Immunol. 2016. PMID: 27253484 Review.
SUMMARY: Given the relative rarity of life-threatening biphasic anaphylaxis and the new context of the NIAID/FAAN standardized definition, further research regarding biphasic anaphylaxis is needed to better elucidate the care model for anaphylaxis patients with a fo …
SUMMARY: Given the relative rarity of life-threatening biphasic anaphylaxis and the new context of the NIAID/FAAN standardized defini …
On the cause and consequences of IgE to galactose-alpha-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy.
Platts-Mills TAE, Commins SP, Biedermann T, van Hage M, Levin M, Beck LA, Diuk-Wasser M, Jappe U, Apostolovic D, Minnicozzi M, Plaut M, Wilson JM. Platts-Mills TAE, et al. J Allergy Clin Immunol. 2020 Apr;145(4):1061-1071. doi: 10.1016/j.jaci.2020.01.047. Epub 2020 Feb 10. J Allergy Clin Immunol. 2020. PMID: 32057766 Free PMC article.
The recognition of delayed reactions to food derived from mammals in patients with IgE to alpha-Gal and also the association with tick bites have been increasing worldwide. In 2018, the National Institute of Allergy and Infectious Dise …
The recognition of delayed reactions to food derived from mammals in patients with IgE to alpha-Gal and also the association with tick bites …
Preface.
Gezmu M, Qin J. Gezmu M, et al. Stat Med. 2018 Jan 30;37(2):179-180. doi: 10.1002/sim.7551. Stat Med. 2018. PMID: 29250840 No abstract available.
Development of a Universal Influenza Vaccine.
Estrada LD, Schultz-Cherry S. Estrada LD, et al. J Immunol. 2019 Jan 15;202(2):392-398. doi: 10.4049/jimmunol.1801054. J Immunol. 2019. PMID: 30617121 Free PMC article. Review.
The severity of the 2017-18 influenza season, combined with the low efficacy for some vaccine components, highlights the need to improve our current seasonal influenza vaccine. Thus, the National Institute of Allergy and Infectious Dis …
The severity of the 2017-18 influenza season, combined with the low efficacy for some vaccine components, highlights the need to improve our …
3,427,248 results
You have reached the last available page of results. Please see the User Guide for more information.